首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1419128

心輸出量監測設備市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、類型、最終用戶和地理位置

Cardiac Output Monitoring Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Type, End User, and Geography

出版日期: 2023年11月12日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

心輸出量監測設備市場預計將從2022年的14.98億美元成長到2030年的22.15億美元；預計2022年至2030年CAGR為5.0%。

心臟左心室或右心室在一分鐘內泵出的血液量稱為心輸出量。它依賴於每搏輸出量和心率。生物阻抗、脈搏輪廓分析、熱稀釋、FloTrac 監測、PiCCO 心輸出量監測、多普勒和 Ficks 原理是心輸出量監測技術的基礎。使用心輸出量監測設備對於評估手術室、重症監護室和其他環境中的患者非常重要。由於技術的發展，鋰稀釋方法使連續即時心輸出量 (CO) 監測成為可能。在整個預測期內，心輸出量監測設備市場預計將經歷該技術的指數級成長。

容易心血管疾病的老年人口不斷增加，推動了心輸出量監測設備市場的成長。

心血管疾病（CVD）和其他需要持續監測和重症監護的重大健康問題在老年族群中越來越常見。 CVD 的幾個主要危險因子是年齡、種族和家族史。吸菸、患有高血壓、高膽固醇、肥胖、缺乏運動、患有糖尿病、飲食不良和飲酒是其他危險因子。

因此，在估計期間，世界人口老化預計將推動心輸出量監測設備市場。根據世界衛生組織（WHO）預測，到2030年，全球60歲以上人口將達14億。隨著年齡的成長，人們變得更容易受到行動限制的影響，因此他們需要醫療援助或援助以避免對其他人的依賴。全球人口正在迅速老化，預計未來幾年老年人數將大幅增加。根據2020年人口普查，美國65歲及以上人口的成長速度比1920-2020年整體人口成長速度近五倍。 2020年，65歲以上的美國人有5,580萬，佔總人口的16.8%。此外，巴西 13% 的人口（超過 3,000 萬名老年人）年齡在 60 歲或以上；到2030年，這一人口預計將達到5,000萬左右，即佔全國人口的24%。因此，容易患心血管疾病的老年人口的增加是心輸出量監測設備市場成長的重要驅動力。

另一方面，患者和醫療保健專業人員特別擔心設備中的網路安全缺陷，尤其是電腦影像擷取設備 (CIED) 等設備，這些設備有可能被重新編程或變得無法操作。美國食品藥物管理局 (FDA) 於 2023 年表示，美敦力 (Medtronic) 召回了約 35 萬個植入式心臟設備，因為這些設備在需要時提供高壓治療的能力始終存在問題。

FDA 網站上的一份建議指出，“低能量電擊或根本不進行電擊可能無法糾正危及生命的心律失常，從而導致心臟驟停、其他嚴重傷害或死亡。” “如果攜帶其中一種設備的患者需要額外的外科手術來移除和更換該設備，則會存在額外的傷害風險。”本次召回涵蓋 2017 年後生產的所有帶有玻璃饋通的心臟再同步治療除顫器 (CRT-D) 和植入式心律轉復除顫器 (ICD)。 FDA 表示，使用這些設備“可能會導致嚴重傷害或死亡”，並將其列為 I 級召回。因此，市場的成長將受到一定程度的限制。

心輸出量監測設備市場根據產品、類型和最終用戶進行細分。市場依產品分為消耗品、配件和儀器。按類型分類，心輸出量監測設備市場分為侵入式和非侵入式。最終用戶將心輸出量監測設備市場細分為醫院、門診手術中心等。依地理位置，心輸出量監測設備市場分為北美（美國、加拿大和墨西哥）、歐洲（英國、德國、法國、義大利、西班牙和歐洲其他地區）、亞太地區（中國、日本、印度）、韓國、澳洲和亞太地區其他地區）、中東和非洲（阿拉伯聯合大公國、沙烏地阿拉伯、南非以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷以及南美洲和非洲其他地區）中美洲）。

根據地理位置，心輸出量監測設備市場分為北美、歐洲、亞太地區、中東和非洲以及南美洲和中美洲。北美是心輸出量監測設備成長的最重要貢獻者。該地區的成長歸因於多種因素，包括藥物開發公司投資的增加、美國政府的大量撥款、大型藥物開發公司的強大影響力、發達的醫療基礎設施以及慢性病的增加。

根據地理位置，心輸出量監測設備市場主要分為北美、歐洲、亞太地區、中東和非洲以及南美洲和中美洲。北美是全球市場成長的最重要貢獻者。就全球心輸出量監測設備市場而言，北美在2021年佔據最大佔有率。這可以歸因於心血管疾病盛行率的上升、醫療保健成本的增加、可支配收入的增加、健康意識的提高、以及切割的可及性

疾病管制與預防中心 (CDC) 和食品藥物管理局 (FDA) 是準備心輸出量監測設備報告時參考的主要主要和次要來源。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：Covid-19 前後的影響

第 12 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第13章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 14 章：心輸出量監測設備市場 - 主要公司簡介

Getinge AB

注意 - 將為以下公司列表提供類似資訊

通用電氣醫療集團
ICU 醫療公司
百特國際公司
愛德華生命科學公司
LiDCOGroup Limited
德爾泰克斯醫療Group Limited
美國通訊委員會
奧西普卡醫療股份有限公司
CNSystems 醫療技術有限公司

第 15 章：附錄

詞彙表
關於 Insight Partners
市場情報雲

簡介目錄

Product Code: TIPRE00011437

The cardiac output monitoring devices market is expected to grow from US$ 1.498 billion in 2022 to US$ 2.215 billion by 2030; it is anticipated to record a CAGR of 5.0% from 2022 to 2030.

The amount of blood pumped by the heart's left or right ventricle in a minute is known as cardiac output. It is reliant on both stroke volume and heart rate. Bioimpedance, pulse contour analysis, thermodilution, FloTrac monitoring, PiCCO cardiac output monitoring, Doppler, and the Ficks principle are the foundations of cardiac output monitoring techniques. Using cardiac output monitoring devices is important in assessing patients in the operating room, critical care unit, and other settings. Thanks to technological developments, the lithium dilution approach has made continuous real-time cardiac output (CO) monitoring possible. Throughout the projection period, the market for cardiac output monitoring devices is anticipated to experience exponential growth for this technique.

The increasing geriatric population prone to CVD drives the growth of the cardiac output monitoring devices market.

Cardiovascular diseases (CVDs) and other significant health issues that require constant monitoring and intensive care are increasingly common in the senior population. A few main risk factors for CVD are age, ethnicity, and family history. Using smoke, having high blood pressure (hypertension), having high cholesterol, being obese, being inactive, having diabetes, having a poor diet, and drinking alcohol are additional risk factors.

As a result, over the estimated period, the world's aging population is expected to drive the cardiac output monitoring device market. According to World Health Organization (WHO) projections, by 2030, there will be 1.4 billion persons over 60 worldwide. With age, people become more susceptible to mobility limitations, as a result of which they require medical assistance or aid to avoid dependence on other individuals. The global population is aging rapidly, and the number of older adults is expected to increase significantly in the coming years. According to the 2020 Census, in the US, the population aged 65 and above surged nearly five times faster than the overall population growth during 1920-2020. In 2020, 55.8 million Americans, i.e., 16.8% of the total population, were aged 65 and above. Further, 13% of Brazil's population-more than 30 million seniors-is aged 60 or more; this population is expected to reach ~50 million by 2030, i.e., 24% of the country's population. Thus, the increasing geriatric population prone to CVD is a significant driver for the growth of the cardiac output monitoring devices market.

On the other hand, patients and healthcare professionals are particularly concerned about cybersecurity flaws in devices, particularly those like computerized image extraction devices (CIEDs), where there is a chance that the gadget may be reprogrammed or rendered inoperable. The Food and Drug Administration (FDA) of the United States stated in 2023 that Medtronic recalled around 350,000 implantable cardiac devices because of persistent problems with their capacity to provide high-voltage therapy when required.

An advisory on the FDA website states that "a reduced-energy shock, or no shock at all, may fail to correct a life-threatening arrhythmia, which can lead to cardiac arrest, other serious injury, or death." "If a patient with one of these devices requires additional surgical procedures to remove and replace the device, there are additional risks of harm." All cardiac resynchronization therapy defibrillators (CRT-Ds) and implanted cardioverter defibrillators (ICDs) with a glassed feedthrough produced after 2017 are covered by this recall. The use of these devices "may cause serious injuries or death," according to the FDA, which has classified this as a Class I recall. Thus, the market's growth would be somewhat restrained.

The cardiac output monitoring devices market is segmented based on product, type, and end user. The market is segmented into consumables, accessories, and instruments based on product. By type, the cardiac output monitoring devices market is segmented into invasive and non-invasive. End-user segments the cardiac output monitoring devices market into hospitals, ambulatory surgical centers, and others. Based on geography, the cardiac output monitoring devices market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Based on geography, the cardiac output monitoring devices market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of cardiac output monitoring devices. This region's growth has been attributed to several factors, including increased investments made by drug development companies, large grants from the US government, a strong presence of major drug development companies, a well-developed healthcare infrastructure, and an increase in chronic diseases.

Based on geography, the cardiac output monitoring devices market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of the global market. Regarding the global market for cardiac output monitoring devices, North America held the biggest share in 2021. This can be attributed to the rise in the prevalence of CVDs, the increase in healthcare costs, the increase in disposable income, the rise in health consciousness, and the accessibility of cutting-ed

Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are key primary and secondary sources referred to while preparing the cardiac output monitoring devices report.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Cardiac Output Monitoring Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Cardiac Output Monitoring Devices Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Cardiac Output Monitoring Devices Market - Global Market Analysis

6.1 Cardiac Output Monitoring Devices - Global Market Overview
6.2 Cardiac Output Monitoring Devices - Global Market and Forecast to 2030

7. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million) - By Products, 2020-2030

7.1 Overview
7.2 Consumables and Accessories
7.3 Instruments

8. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

8.1 Overview
8.2 Invasive
8.3 Non-invasive

9. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgical Centres
9.4 Others

10. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Cardiac Output Monitoring Devices Market Overview
- 10.1.2 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts to 2030
- 10.1.3 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By Products
- 10.1.4 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By Type
- 10.1.5 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Cardiac Output Monitoring Devices Market
    - 10.1.6.1.1 United States Cardiac Output Monitoring Devices Market, by Products
    - 10.1.6.1.2 United States Cardiac Output Monitoring Devices Market, by Type
    - 10.1.6.1.3 United States Cardiac Output Monitoring Devices Market, by End User
  - 10.1.6.2 Canada Cardiac Output Monitoring Devices Market
    - 10.1.6.2.1 Canada Cardiac Output Monitoring Devices Market, by Products
    - 10.1.6.2.2 Canada Cardiac Output Monitoring Devices Market, by Type
    - 10.1.6.2.3 Canada Cardiac Output Monitoring Devices Market, by End User
  - 10.1.6.3 Mexico Cardiac Output Monitoring Devices Market
    - 10.1.6.3.1 Mexico Cardiac Output Monitoring Devices Market, by Products
    - 10.1.6.3.2 Mexico Cardiac Output Monitoring Devices Market, by Type
    - 10.1.6.3.3 Mexico Cardiac Output Monitoring Devices Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Cardiac Output Monitoring Devices Market - Key Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies